Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Injection Phase III Trial in Type 2 Diabetes Mellitus
CTR20200348Phase 3Completed
- Sponsor
- The United Laboratories International Holdings
- Start
- Jun 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by The United Laboratories International Holdings. Started Jun 2020; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20200348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200348.